Psych Congress: Bipolar Disorder Across the Spectrum: Novel Screening Tools and Treatment Options

After participating in this activity, learners should be better able to:

• Describe tactics to differentiate and identify various symptom domains in bipolar disorder
• Review the benefits and drawbacks of both traditional and newer screening scales used for bipolar identification
• Analyze treatment targets and efficacy and safety outcomes for the most recently updated and emerging bipolar medications
• Apply updated knowledge regarding bipolar diagnosis and management to real-world treatment plans

CLAIMING CREDIT
To be eligible for credit, participants must complete the online activity and the evaluation. Upon completing the activity, there will be instructions on how to complete the evaluation and print a certificate or other documentation of credit.

Release Date: December 15, 2021
Expiration Date: December 31, 2022
Estimated Time to Complete: 90 minutes

There is no fee associated with this activity.

COMMERCIAL SUPPORT
NACCME would like to thank the following companies who have supported "Bipolar Disorder Across the Spectrum: Novel Screening Tools and Treatment Options" through educational grant support: Alkermes, Inc. and Intra-Cellular Therapies, Inc.

CONTINUING EDUCATION
In support of improving patient care, NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.